Latest News

Detroit-Area Life Sciences Firm Pledges More Than $250,000 in Employee Hours to Local Volunteer Initiatives

CANTON, Mich. (October 5, 2018) – MMS Holdings Inc. (MMS) – award-winning, data-focused CRO – announced today its renewed dedication to the local communities surrounding Detroit and Ann Arbor by allocating a substantial amount of colleague time to volunteer initiatives over the next year. Re-launched as part of its #OneMMS campaign, the value of this investment locally is worth $251,640.

Through the program, MMS employees are able to set time aside during the work day for charitable initiatives of their own choosing.

“We truly value each and every one of our colleagues, and we care about what is important to them,” said Michelle Gayari, Executive Director, Global Operations, MMS. “We have a great group of people who genuinely want to give back. Allowing colleagues to choose their own volunteer initiatives amongst the communities in which they live, work, and play was well received.”

This recommitment to their volunteer program was announced and a central focus of the company’s 9th Annual Scientific Symposium, hosted at its headquarters yesterday.

“This is a fundamental shift in the way that many companies approach volunteer initiatives. Colleagues who choose their own charity to support will generally be more apt to follow through and make the most out of the program,” said Samantha Foksa, Associate Manager, HR & Administration.

A volunteer program has been in place at MMS for nine years. Stay up-to-date with news and volunteer initiatives by following MMS at: www.linkedin.com/company/mms-holdings-inc-

About MMS Holdings
MMS is a global, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex regulatory submission challenges. As a data-focused CRO, we are pioneers and leaders in regulatory submissions for our sponsors. Strong industry experience and a data-driven approach to drug development make MMS a valuable partner in creating compelling submissions that meet rigorous regulatory standards. MMS was named Best Global Biotech CRO in the 2018 International Life Sciences Awards. For more information, visit www.mmsholdings.com.

Media contact
Avery Zimmerman
media@mmsholdings.com

Suggested For You

news

October 15th, 2024

MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)

news

July 17th, 2024

Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization

news

April 4th, 2024

MMS Hires Pharmaceutical Industry Veteran James Zee for Global Biometrics Leadership in Europe Amid Strong Regional Growth

news

March 6th, 2024

MMS Holdings Inc – A Data-Centric CRO Powerhouse Reshaping Drug Development on a Global Scale

news

December 13th, 2023

MMS Supported Lykos Therapeutics: NDA Submitted to FDA for First Psychedelic-Assisted Therapy for PTSD

news

April 18th, 2023

MMS Named Great Place to Work in the UK as Growth in the Region Doubles

news

March 21st, 2023

MMS Scientific Advisory Board’s New Members Expand CRO’s Therapeutic Expertise

news

February 21st, 2023

MMS Partners with I-ACT to Advance Children’s Clinical Trials

news

February 7th, 2023

Award-Winning Data CRO Expands Executive Leadership to Support Company’s Next Stage of Growth

news

January 11th, 2023

MMS Named a Great Place to Work in India

news

November 21st, 2022

MMS Named Michigan Top Workplace For The Second Consecutive Year

news

August 16th, 2022

Together Trial with EDC Database Designed by MMS Wins Trial of the Year